-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
September 01, 2011 - Until 2009, 16 maternal deaths and 12 cases of
maternal cardiovascular events (hypertension,
myocardial … important criterion
that increases our confidence in an estimate.9 However,
adverse events such as death, hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
January 30, 2013 - Until 2009, 16 maternal deaths and
12 cases of maternal cardiovascular
events (hypertension, myocardial … Until 2009, 16 maternal deaths and 12 cases of maternal
cardiovascular events (hypertension, myocardial
-
psnet.ahrq.gov/perspective/integrating-multiple-medication-decision-support-systems-how-will-we-make-it-all-work
May 01, 2008 - Integrating Multiple Medication Decision Support Systems: How Will We Make It All Work?
Josh Peterson, MD, MPH | May 1, 2018
Also Read a Conversation
View more articles from the same authors.
Citation Text:
Peterson JF. Integrating Multiple Medication Decision …
-
www.ahrq.gov/research/findings/studies/index.html
January 01, 2024 - AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results 1 to 25 of 12759 Research Studies Displayed
Pagination
1
2
3
4
5
… More pages
…
-
effectivehealthcare-admin.ahrq.gov/products/progestogens-preterm-birth/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp
June 01, 2017 - Elixhauser Comorbidity Software, Version 3.7
An official website of the Department of Health & Human Services
Search All AHRQ Websites
Careers
Contact Us
Espanol
FAQs
Email …
-
www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/medication/tool-safe-oxytocin.html
July 01, 2023 - Safe Medication Administration: Oxytocin
AHRQ Safety Program for Perinatal Care
Purpose of the tool: This tool describes the key perinatal safety elements with examples for the safe administration of oxytocin during labor. The key elements are presented within the framework of the Comprehensive U…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - Hypertension and dyslipidemia also improved, yielding
50-84% reductions in predicted 10-year cardiovascular … recorded in 61.4% of implanted eyes (SOC, 5.8%) at any time and
33.8% required surgery for ocular hypertension … and eye disease history, and other risk factors
(i.e., older age, poor glucose control, pregnancy, hypertension … The main nonocular AEs [adverse
events] were nasopharyngitis (18.8%) and hypertension (10.4%). … DME, including diabetic history (T1DM at higher risk), older age, poor glucose control,
pregnancy, hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
May 01, 2018 - , neuropathy (nerve problems), retinopathy (eye problems), and
macrovascular complications such as hypertension … vs. 9.05%
(control)
Comorbidities: BMI
(kg/m2:) 34.07
(intervention) vs. 34.58
(control)
62% hypertension … 76.1% of
ppts obese (BMI>30
kg/m2)
Mean PHQ-9 of 5.2
indicating minimal to mild
depression
63.2% hypertension … Comorbidities:
61% hypertension
59% hypercholesterolemia
8% coronary artery
disease
12% microvascular … Insulin pump: NR
Baseline HbA1c: 9.86% in
intervention vs. 9.76% in
control
Comorbidities:
40% Hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - Hypertension and dyslipidemia also improved, yielding
50-84% reductions in predicted 10-year cardiovascular … recorded in 61.4% of implanted eyes (SOC, 5.8%) at any time and
33.8% required surgery for ocular hypertension … and eye disease history, and other risk factors
(i.e., older age, poor glucose control, pregnancy, hypertension … The main nonocular AEs [adverse
events] were nasopharyngitis (18.8%) and hypertension (10.4%). … DME, including diabetic history (T1DM at higher risk), older age, poor glucose control,
pregnancy, hypertension
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
May 01, 2018 - , neuropathy (nerve problems), retinopathy (eye problems), and
macrovascular complications such as hypertension … vs. 9.05%
(control)
Comorbidities: BMI
(kg/m2:) 34.07
(intervention) vs. 34.58
(control)
62% hypertension … 76.1% of
ppts obese (BMI>30
kg/m2)
Mean PHQ-9 of 5.2
indicating minimal to mild
depression
63.2% hypertension … Comorbidities:
61% hypertension
59% hypercholesterolemia
8% coronary artery
disease
12% microvascular … Insulin pump: NR
Baseline HbA1c: 9.86% in
intervention vs. 9.76% in
control
Comorbidities:
40% Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.pdf
January 01, 2020 - caused by
tuberculosis or sexually
transmitted disease) 19,317 21.89 22.71 3.8
98: Essential hypertension … 21,797 11.97 12.30 2.8
99: Hypertension with
complications and secondary
hypertension 101,943 … 182: Hemorrhage during
pregnancy; abruptio placenta;
placenta previa 266 17.67 18.80 6.4
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.jsp
January 01, 2020 - tuberculosis or sexually transmitted disease)
19,317
21.89
22.71
3.8
98: Essential hypertension … 21,797
11.97
12.30
2.8
99: Hypertension with complications and secondary hypertension … Hemorrhage during pregnancy; abruptio placenta; placenta previa
266
17.67
18.80
6.4
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2017.pdf
January 01, 2017 - caused by
tuberculosis or sexually
transmitted disease) 19,317 21.89 22.71 3.8
98: Essential hypertension … 21,797 11.97 12.30 2.8
99: Hypertension with
complications and secondary
hypertension 101,943 … 182: Hemorrhage during
pregnancy; abruptio placenta;
placenta previa 266 17.67 18.80 6.4
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.pdf
January 01, 2019 - caused by
tuberculosis or sexually
transmitted disease) 19,317 21.89 22.71 3.8
98: Essential hypertension … 21,797 11.97 12.30 2.8
99: Hypertension with
complications and secondary
hypertension 101,943 … 182: Hemorrhage during
pregnancy; abruptio placenta;
placenta previa 266 17.67 18.80 6.4
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2016.pdf
January 01, 2016 - caused by
tuberculosis or sexually
transmitted disease) 19,317 21.89 22.71 3.8
98: Essential hypertension … 21,797 11.97 12.30 2.8
99: Hypertension with
complications and secondary
hypertension 101,943 … 182: Hemorrhage during
pregnancy; abruptio placenta;
placenta previa 266 17.67 18.80 6.4
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2018.pdf
January 01, 2018 - caused by
tuberculosis or sexually
transmitted disease) 19,317 21.89 22.71 3.8
98: Essential hypertension … 21,797 11.97 12.30 2.8
99: Hypertension with
complications and secondary
hypertension 101,943 … 182: Hemorrhage during
pregnancy; abruptio placenta;
placenta previa 266 17.67 18.80 6.4
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2018.jsp
January 01, 2018 - tuberculosis or sexually transmitted disease)
19,317
21.89
22.71
3.8
98: Essential hypertension … 21,797
11.97
12.30
2.8
99: Hypertension with complications and secondary hypertension … Hemorrhage during pregnancy; abruptio placenta; placenta previa
266
17.67
18.80
6.4
183: Hypertension
-
cdsic.ahrq.gov/sites/default/files/2023-10/Final%20OO%20Patient%20Outcomes%20of%20PC%20CDS%20to%20AHRQ%2010.6.23.pdf
January 01, 2023 - Records included the
drug name, quantity, dose strength, and dose
frequency of hypertension medication … Records included the
drug name, quantity, dose strength, and dose
frequency of hypertension medication … Records included the
drug name, quantity, dose strength, and dose
frequency of hypertension medication … Impact of patient knowledge on hypertension treatment adherence and efficacy: A
single-centre study
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/case_example_4.pdf
October 01, 2016 - discussions about following up on approximately
800 patients who have completed the PAM, setting goals for hypertension